跳至主要内容
临床试验/EUCTR2020-001379-34-ES
EUCTR2020-001379-34-ES进行中(未招募)1 期

Sedation with sevoflurane versus propofol in patients with Acute Respiratory Distress Syndrome caused by COVID-19 infection

Instituto de Investigación Sanitaria INCLIVA0 个研究点目标入组 50 人开始时间: 2020年4月14日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Age 18 years or more.
  • - Diagnosis of Acute Respiratory Distress Syndrome caused by COVID19 infection.
  • - Signature of Patient's Consent or Verbal Consent of Legal Representative
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 40

排除标准

  • - Intracranial hypertension
  • - Hypersensitivity to the active ingredient (propofol or sevoflurane) or to any of the excipients
  • - Current volume < 250ml
  • - History of malignant hyperthermia
  • - Liver failure
  • - Neutropenia (<0.5x109)
  • - Pregnant or lactating women
  • - Have received chemotherapy in the last month since their inclusion in the study

研究者

发起方
Instituto de Investigación Sanitaria INCLIVA

相似试验

Sedation with sevoflurane versus propofol in... | 临床试验